A new Journal of Obstetrics and Gynaecology Research study offers infertile women new information regarding their expected probabilities of becoming pregnant and may help them select the optimal treatment based on their various risk factors.
A new Journal of Obstetrics and Gynaecology Research study offers infertile women new information regarding their expected probabilities of becoming pregnant and may help them select the optimal treatment based on their various risk factors.
In an analysis of the medical records of 1,864 female infertile patients in Tokyo from 2000-2015, 49.4% and 21.9% of patients conceived after being treated with assisted reproductive technology (ART) and non-ART, respectively. Age over 35 years, advanced endometriosis, and a past history or current presence of uterine fibroids had negative impacts on the outcome of non-ART. The effect of advanced endometriosis was especially high for patients in their 30s. ART treatment for patients with advanced endometriosis was effective.
ART treatments include in vitro fertilization and intracytoplasmic sperm injection, while non-ART treatments include mild ovarian stimulation together with timed intercourse and/or intra-uterine insemination.
“Some women in their early 30's may be suffering from advanced stage endometriosis and will remain to be infertile unless they are extensively treated,” said co-author Dr. Osamu Wada-Hiraike, of The University of Tokyo.
Additional Information
Link to Study: https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/jog.13826
About Journal
The Journal of Obstetrics and Gynaecology Research is the official Journal of the Asia and Oceania Federation of Obstetrics and Gynecology and of the Japan Society of Obstetrics and Gynecology, and aims to provide a medium for the publication of articles in the fields of obstetrics and gynecology.
The Journal publishes original research articles, case reports, review articles and letters to the editor. The Journal will give publication priority to original research articles over case reports. Accepted papers become the exclusive licence of the Journal. Manuscripts are peer reviewed by at least two referees and/or Associate Editors expert in the field of the submitted paper.
About Wiley
Wiley is a global leader in education and scholarly research. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at www.wiley.com.
Penny Smith (UK) +44 (0) 1243 770448
newsroom@wiley.com
Follow us on Twitter @WileyNews